Nova One Advisor

Global Transcatheter Embolization and Occlusion Devices Market Size, Share, Forecast Report, 2020-2027

Status: Published Category: Healthcare Insight Code: 1914 Format: PDF / PPT / Excel

Content


Warning: DOMDocument::loadHTML(): htmlParseEntityRef: no name in Entity, line: 16 in /home/multiwpmr/public_html/report-details.php on line 448

Warning: DOMDocument::loadHTML(): htmlParseEntityRef: no name in Entity, line: 55 in /home/multiwpmr/public_html/report-details.php on line 448

Warning: DOMDocument::loadHTML(): htmlParseEntityRef: no name in Entity, line: 61 in /home/multiwpmr/public_html/report-details.php on line 448

Warning: DOMDocument::loadHTML(): htmlParseEntityRef: no name in Entity, line: 64 in /home/multiwpmr/public_html/report-details.php on line 448
The report provides rational insights along with historical and forecast data to aid in better understanding of the Global Transcatheter Embolization and Occlusion Devices Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of the Transcatheter Embolization and Occlusion Devices market. This study also provides a detailed overview of the opportunities along with the current trends observed in the target market.

According to the report, the global transcatheter embolization and occlusion devices market was valued at US$ 2,957.4 Mn in 2018 and is projected to expand at a CAGR of 7.8% from 2019 to 2027. In terms of volume, the transcatheter embolization and occlusion devices were accounted at 72,93,954 units in 2018.

Transcatheter embolization is a process of placing synthetic material or medication called embolic agent into blood vessels through a catheter to block blood flow toward a specific area of the body.

Embolization is a highly effective way to prevent abnormal bleeding and is minimally invasive as compared to open surgery. Additionally, the technology is proving its efficiency in treatment while performing complex surgeries.

Surge in incidence of cardiovascular diseases, respiratory disorders, and cancer are anticipated to drive demand for transcatheter embolization and occlusion devices during the forecast period.

North America dominated the global transcatheter embolization and occlusion devices market in 2018 and the trend is anticipated to continue during the forecast period. Highly structured health care industry, increased adoption of minimally invasive surgeries, and introduction of the Affordable Care Act in the U.S. are expected to drive the market in North America.

Asia Pacific is likely to be a highly lucrative market for transcatheter embolization and occlusion devices and it is expected to expand at a high CAGR during the forecast period

The report covers major players operating in the market along with the key strategies implemented to achieve a competitive edge against a majority of the vendors which provides a competitive outlook of the industry. The competitive landscape further includes details about different players and their position on a global and a local level is also explained in detail in this compiled study. These insights were prepared through mapping business strategies and products that offer high revenue generation capacities. Key players of the global Transcatheter Embolization and Occlusion Devices market are included as given below:

BTG plc

Boston Scientific Corporation

Medtronic plc

Penumbra, Inc.

Cook Medical

Edwards Lifesciences Corporation

Merit Medical Systems

Johnson & Johnson Services, Inc.

Pfizer, Inc.

Stryker Corporation

Terumo Corporation

Sirtex Medical Limited

Abbott Laboratories.

The global Transcatheter Embolization and Occlusion Devices market has been segmented as below:

Global Transcatheter Embolization and Occlusion Devices Market, by Product

Embolization Coils

Coiling Assist Devices

Embolization Particles

Flow Diverter Devices

Liquid Embolics

Accessories

Global Transcatheter Embolization and Occlusion Devices Market, by Application

Peripheral Vascular Disease

Neurology

Oncology

Urology

Others

Global Transcatheter Embolization and Occlusion Devices Market, by End-user

Hospitals

Ambulatory Surgical Centers

Clinics

Global Transcatheter Embolization and Occlusion Devices Market, by Region

North America

o U.S.

o Canada

Europe

o Germany

o U.K.

o France

o Italy

o Spain

o Rest of Europe

Asia Pacific

o China

o India

o Japan

o Australia & New Zealand

o Rest of Asia Pacific

Latin America

o Brazil

o Mexico

o Rest of Latin America

Middle East & Africa

o GCC Countries

o South Africa

o Rest of Middle East & Africa



Reasons to Purchase this Report:

Estimates Transcatheter Embolization and Occlusion Devices development trends with SWOT analysis

Detailed business profiles including product offerings, recent developments, key financial information, and strategies employed by main market players

Analysis of various regions and countries that includes the demand and supply based actions, which consequently have a major influence on the market's expansion

Market dynamics scenario, along with growth opportunities for players in the years to come

Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the mentioned forecast period

Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects

  • Insight Code: 1914
  • No. of Pages: 250
  • Format: PDF/PPT/Excel
  • Published: June 2020
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034